Wang, Hui http://orcid.org/0000-0003-1494-6668
Amiel, Thomas
Würnschimmel, Christoph
Langbein, Thomas
Steiger, Katja
Rauscher, Isabel
Horn, Thomas
Maurer, Tobias
Weber, Wolfgang
Wester, Hans-Juergen
Knorr, Karina
Eiber, Matthias
Funding for this research was provided by:
DFG Sonderforschungsbereich 824 (B11, B11, Z2)
China Scholarship Council
Technische Universität München
Article History
Received: 7 June 2021
Accepted: 28 July 2021
First Online: 21 August 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the Declaration of Helsinki. This retrospective study has been approved by the Ethics Committee of the Technical University Munich (750/20 S-KH).
: Not applicable.
: ME reports patent application for rhPSMA and prior consulting activities for Blue Earth Diagnostics, Progenics Pharmaceuticals, Point Biopharma and Janssen Pharmaceuticals. Other authors declare that they have no competing interests.